Evaluation of human recombinant tissue factor-activated thromboelastography in 49 dogs with neoplasia

Journal of Veterinary Internal Medicine

Volumn 22, Issue 1, 2008, Pages 140-147

  Kristensen, A T ^a   Wiinberg, B ^a   Jessen, L R ^a   Andreasen, E ^a   Jensen, A L ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cancer; Canine; Hemostasis; Hypercoagulability; Hypocoagulability

Indexed keywords

RECOMBINANT PROTEIN; THROMBOPLASTIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLOOD CLOTTING DISORDER; DOG; DOG DISEASE; EVALUATION; HEMOSTASIS; HUMAN; METHODOLOGY; NEOPLASM; PROSPECTIVE STUDY; THROMBOELASTOGRAPHY;

ANIMALS; DOG DISEASES; DOGS; HEMOSTASIS; HEMOSTATIC DISORDERS; HUMANS; NEOPLASMS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; THROMBELASTOGRAPHY; THROMBOPLASTIN;

ANIMALIA; CANIS FAMILIARIS;

EID: 40549083747     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2008.0030.x     Document Type: Article

References (36)

1. Francis JL, Biggerstaff J, Amirkhosravi A. Hemostasis and malignancy. Serain Thromb Hemost 1998;24:93-109.
2. Rickles FR. Mechanisms of cancer-induced thrombosis in cancer. Pathophysiol Haemost Thromb 2006;35:103-110.
3. Lecumberri R, Paramo JA, Rocha E. Anticoagulant treatment and survival in cancer patients. The evidence from clinical studies. Haematologica 2005;90:1258-1266.
4. Madewell BR, Feldman BF, O'Neill S. Coagulation abnormalities in dogs with neoplastic disease. Thromb Haemost 1980;44:35-38.
5. O'Donnell MR, Slichter SJ, Weiden PL, Storb R. Platelet and fibrinogen kinetics in canine tumors. Cancer Res 1981;41:1379-1383.
6. Grindem CB, Breitschwerdt EB, Corbett WT, et al. Thrombocytopenia associated with neoplasia in dogs. J Vet Intern Med 1994;8:400-405.
7. Helfand S. Platelets and neoplasia. Vet Clin North Am Small Anim Pract 1988;18:131-156.
8. O'Keefe D, Couto G. Coagulation abnormalities associated with neoplasia. Vet Clin North Am Small Anim Pract 1988;18:157-168.
9. Hammer AS, Couto CG, Swardson C, Getzy D. Hemostatic abnormalities in dogs with hemangiosarcoma. J Vet Intern Med 1991;5:11-14.
10. Hargis AM, Feldman BF. Evaluation of hemostatic defects secondary to vascular tumors in dogs: 11 cases (1983-1988). J Am Vet Med Assoc 1991;198:891-864.
11. Maruyama H, Miura T, Sakai M, et al. The incidence of disseminated intravascular coagulation in dogs with malignant tumor. J Vet Med Sci 2004;66:573-575.
12. McNiel EA, Ogilvie GK, Fettman MJ, Salman MD. Platelet hyperfunction in dogs with malignancies. J Vet Intern Med 1997;11:178-182.
13. Thomas JS, Rogers KS. Platelet aggregation and adenosine triphosphate secretion in dogs with untreated multicentric lymphoma. J Vet Intern Med 1999;13:319-322.
14. Mischke R, Freund M, Leinemann-Fink T, et al. Changes in hemostasis of dogs with acute lymphoblastic leukaemia. Berl Munch Tierarztl Wochenschr 1998;111:53-59.
15. Mischke R, Wohlsein P, Busse L, Pohlenz J. Disseminated intravascular coagulation and hyperfibrinolysis in dogs with metastasizing mammary carcinoma. Schweiz Arch Tierheilkd 1998;140:497-505.
16. Stockhaus C, Kohn B, Rudolph R, et al. Correlation of haemostatic abnormalities with tumour stage and characteristics in dogs with mammary carcinoma. J Small Anim Pract 1999;40:326-331.
17. Johnson LR, Lappin MR, Baker DC. Pulmonary thromboembolism in 29 dogs: 1985-1995. J Vet Intern Med 1999;13:338-345.
18. LaRue MJ, Murtaugh MJ. Pulmonary thromboembolism in dogs: 47 cases (1986-1987). J Am Vet Med Assoc 1990;197:1368-1372.
19. Van Winkle TJ, Bruce E. Thrombosis of the portal vein in eleven dogs. Vet Pathol 1993;30:28-35.
20. Ruf W. Molecular regulation of blood clotting in tumor biology. Haemostasis 2001;31:5-7.
21. Ruf W, Mueller BM. Thrombin generation and the pathogenesis of cancer. Semin Thromb Hemost 2006;32(Suppl 1):61-68.
22. Mueller BM, Ruf W. Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. J Clin Invest 1998;101:1372-1378.
23. Rak J, Milsom C, May L, et al. Tissue factor in cancer and angiogenesis: The molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. Semin Thromb Hemost 2006;32:54-70.
24. Amirkhosravi A, Mousa SA, Amaya M, Francis JL. Antimetastatic effect of tinzaparin, a low-molecular-weight heparin. J Thromb Haemost 2003;1:1972-1976.
25. Amirkhosravi A, Meyer T, Chang JY, et al. Tissue factor pathway inhibitor reduces experimental lung metastasis of B16 melanoma. Thromb Haemost 2002;87:930-936.
26. Langer F, Amirkhosravi A, Ingersoll SB, et al. Experimental metastasis and primary tumor growth in mice with hemophilia A. J Thromb Haemost 2006;4:1056-1062.
27. Banke IJ, Arlt MJ, Mueller MM, et al. Effective inhibition of experimental metastasis and prolongation of survival in mice by a potent factor Xa-specific synthetic serine protease inhibitor with weak anticoagulant activity. Thromb Haemost 2005;94:1084-1093.
28. Lopez-Pedrera C, Barbarroja N, Dorado G, et al. Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies. Leukemia 2006;20:1331-1340, epub May 25, 2006.
29. Nelson OL, Andreasen C. The utility of plasma D-dimer to identify thromboembolic disease in dogs. J Vet Intern Med 2003;17:830-834.
30. Griffin A, Callan MB, Shoter FS, et al. Evaluation of a canine D-dimer point-of-care test kit for use in samples obtained from dogs with disseminated intravascular coagulation, thromboembolic disease, and hemorrhage. Am J Vet Res 2003;64:1562-1569.
31. Wiinberg B, Jensen AL, Rojkjaer R, et al. Validation of human recombinant tissue factor activated thromboelastography on citrated whole blood from clinically healthy dogs. Vet Clin Pathol 2005;34:389-393.
32. Wiinberg B, Jensen AL, Kjelgaard-Hansen M, et al. Study on biological variation of hemostatic parameters in clinically healthy dogs. Vet J 2007;174:62-68.
33. Otto CM, Rieser TM, Brooks MB, Russel MW. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000;217:1500-1504.
34. McCrath DJ, Cerboni E, Frumento RJ, et al. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005;100:1576-1583.
35. Gurbel PA, Bliden KP, Guyer K, et al. Platelet reactivity in patients and recurrent events post-stenting: Results of the PREPARE POST-STENTING Study. J Am Coll Cardiol 2005;46:1820-1826.
36. Drake TA, Morrisey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Am J Pathol 1989;134:1087-1097.